Mirum Pharmaceuticals (MIRM) Gross Profit: 2020-2025
Historic Gross Profit for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to $107.5 million.
- Mirum Pharmaceuticals' Gross Profit rose 54.48% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $377.0 million, marking a year-over-year increase of 68.97%. This contributed to the annual value of $255.2 million for FY2024, which is 83.19% up from last year.
- Latest data reveals that Mirum Pharmaceuticals reported Gross Profit of $107.5 million as of Q3 2025, which was up 2.98% from $104.4 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Gross Profit ranged from a high of $107.5 million in Q3 2025 and a low of -$3.4 million during Q1 2021.
- Its 3-year average for Gross Profit is $63.2 million, with a median of $57.6 million in 2024.
- Data for Mirum Pharmaceuticals' Gross Profit shows a peak YoY skyrocketed of 1,036.72% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Gross Profit stood at $3.1 million in 2021, then soared by 789.29% to $27.9 million in 2022, then skyrocketed by 59.59% to $44.5 million in 2023, then skyrocketed by 72.08% to $76.6 million in 2024, then soared by 54.48% to $107.5 million in 2025.
- Its Gross Profit stands at $107.5 million for Q3 2025, versus $104.4 million for Q2 2025 and $88.6 million for Q1 2025.